The influence of tumour necrosis factor α inhibitors treatment – etanercept on serum concentration of biomarkers of inflammation and cartilage turnover in psoriatic arthritis patients

INTRODUCTION: Effective treatment in psoriatic arthritis (PsA) patients can protect them from severe musculoskeletal complications. For appropriate monitoring of anti-tumour necrosis factor α (anti-TNF-α) treatment in PsA, specific biomarkers are needed. AIM: To investigate whether biological treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Waszczykowski, Michał, Bednarski, Igor, Lesiak, Aleksandra, Waszczykowska, Elżbieta, Narbutt, Joanna, Fabiś, Jarosław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874864/
https://www.ncbi.nlm.nih.gov/pubmed/33603621
http://dx.doi.org/10.5114/ada.2020.96705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874864/
https://www.ncbi.nlm.nih.gov/pubmed/33603621
http://dx.doi.org/10.5114/ada.2020.96705

Ejemplares similares